Abstract Details
|
Katherine Werbaneth, MD
(Stanford University Medical Center)
PRESENTER |
Dr. Werbaneth has nothing to disclose. |
| Joyce A. Cramer (Yale University School of Medicine) | No disclosure on file |
| No disclosure on file | |
| Robert S. Fisher, MD, PhD, FÂé¶¹´«Ã½Ó³» (Stanford University Medical Center) | Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Epi-Minder Study, Australia (Mark Cook, PI). Dr. Fisher has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for START study (Hal Blumenfeld, PI). Dr. Fisher has stock in Avails Medical stock options (drug level testing). Dr. Fisher has stock in Eysz stock options (eye-movement seizure detection). Dr. Fisher has stock in Irody stock options (health records databases). Dr. Fisher has stock in Smart-Monitor stock options (shake-detector watch). Dr. Fisher has stock in Zeto stock options, dry, wireless EEG. The institution of Dr. Fisher has received research support from NaviFUS (focused ultrasound). |